IV Diazoxide

DRUG2 trials

Sponsors

Johns Hopkins University

Conditions

Myocardial Stunning

Phase 1

Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

WithdrawnNCT04830982

Johns Hopkins UniversityMyocardial Stunning

Start: 2023-09-01End: 2025-10-30Updated: 2022-09-19

Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial

CompletedNCT06308107

Johns Hopkins UniversityMyocardial Stunning

Start: 2024-07-08End: 2025-05-09Updated: 2025-07-14